Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122528 | PMC |
| http://dx.doi.org/10.1128/CVI.00358-10 | DOI Listing |
Publication Analysis
Top Keywords
memory response
8
booster dose
8
hepatitis vaccine
8
successful memory
4
response booster
4
dose virosome-formulated
4
virosome-formulated hepatitis
4
vaccine delayed
4
delayed years
4
years boosting
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!